ES2144394T3 - Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis. - Google Patents

Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis.

Info

Publication number
ES2144394T3
ES2144394T3 ES90402590T ES90402590T ES2144394T3 ES 2144394 T3 ES2144394 T3 ES 2144394T3 ES 90402590 T ES90402590 T ES 90402590T ES 90402590 T ES90402590 T ES 90402590T ES 2144394 T3 ES2144394 T3 ES 2144394T3
Authority
ES
Spain
Prior art keywords
peptides
polypeptides
tuberculosis
diagnosis
code
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90402590T
Other languages
English (en)
Inventor
Jean Content
Wit Lucas De
Bruyn Jacqueline De
Vooren Jean Paul Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of ES2144394T3 publication Critical patent/ES2144394T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Endoscopes (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

EL INVENTO SE REFIERE A POLIPEPTIDOS Y PEPTIDOS RECOMBINANTES Y PARTICULARMENTE AL POLIPEPTIDO QUE CONTIENE EN SU CADENA POLIPEPTIDICA LA SIGUIENTE SECUENCIA DE ACIDO AMINO: SE EXTIENDE A PARTIR DE LA EXTREMIDAD CONSTITUIDA POR UN NUCLEOTIDO EN LA POSICION (1), HASTA LA EXTREMIDAD CONSTITUIDA POR UN NUCLEOTIDO EN LA POSICION (194) ESTA REPRESENTA EN LAS FIG. 4A Y 4B. LOS POLIPEPTIDOS Y PEPTIDOS DEL INVENTO PUEDEN USARSE PARA LA DIAGNOSIS DE LA TUBERCULOSIS, Y TAMBIEN PUEDEN FORMAR PARTE COMO PRINCIPIO ACTIVO DE LA PREPARACION DE UNA VACUNA CONTRA LA TUBERCULOSIS.
ES90402590T 1989-09-19 1990-09-19 Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis. Expired - Lifetime ES2144394T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402571 1989-09-19

Publications (1)

Publication Number Publication Date
ES2144394T3 true ES2144394T3 (es) 2000-06-16

Family

ID=8202993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90402590T Expired - Lifetime ES2144394T3 (es) 1989-09-19 1990-09-19 Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis.

Country Status (10)

Country Link
US (3) US5916558A (es)
JP (2) JP2756368B2 (es)
AT (1) ATE189684T1 (es)
AU (1) AU631460B2 (es)
CA (1) CA2042016C (es)
DD (1) DD295869A5 (es)
DE (1) DE69033453T2 (es)
ES (1) ES2144394T3 (es)
IL (1) IL95742A (es)
WO (1) WO1991004272A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042016C (en) * 1989-09-19 2004-04-06 Jean Content Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
US7083797B2 (en) * 1990-09-19 2006-08-01 N.V. Innogenetics S.A. 32-kDa protein derived from Mycobacterium tuberculosis and related peptides
CN1103781C (zh) * 1993-11-23 2003-03-26 加利福尼亚大学 丰富的细胞外产物和其生产与使用方法
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5935568A (en) * 1995-05-18 1999-08-10 National Jewish Medical & Research Center Gene therapy for effector cell regulation
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US7288261B2 (en) * 2000-07-10 2007-10-30 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
GB0022017D0 (en) * 2000-09-08 2000-10-25 Univ Dundee Cell assays
WO2003012395A2 (en) * 2001-08-02 2003-02-13 New York University Early detection of mycobacterial disease using peptides
NZ555907A (en) 2004-11-16 2009-12-24 Aeras Global Tb Vaccine Found Multivalent vaccines comprising recombinant viral vectors
WO2007041539A1 (en) 2005-09-30 2007-04-12 Transcutaneous Technologies, Inc. Iontophoresis apparatus and method for the diagnosis of tuberculosis
US8628597B2 (en) * 2009-06-25 2014-01-14 3M Innovative Properties Company Method of sorting abrasive particles, abrasive particle distributions, and abrasive articles including the same
US8784774B2 (en) 2011-09-16 2014-07-22 General Electric Company Labeled molecular imaging agents and methods of use
US9468693B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use
US9468692B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
BE905582A (fr) * 1986-10-09 1987-04-09 Province De Brabant Inst Paste Procede de production et de purification d'antigenes proteiques de mycobacterium bovis-bcg, produits obtenues et leurs applications.
GB8709803D0 (en) * 1987-04-24 1987-05-28 Mcfadden J J Treatment of crohn's disease &c
US7083797B2 (en) * 1990-09-19 2006-08-01 N.V. Innogenetics S.A. 32-kDa protein derived from Mycobacterium tuberculosis and related peptides
CA2042016C (en) * 1989-09-19 2004-04-06 Jean Content Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis

Also Published As

Publication number Publication date
JPH09234096A (ja) 1997-09-09
JP2756368B2 (ja) 1998-05-25
DE69033453D1 (de) 2000-03-16
IL95742A0 (en) 1991-06-30
ATE189684T1 (de) 2000-02-15
DD295869A5 (de) 1991-11-14
US6531138B1 (en) 2003-03-11
CA2042016A1 (en) 1991-03-20
WO1991004272A1 (en) 1991-04-04
US5916558A (en) 1999-06-29
AU631460B2 (en) 1992-11-26
CA2042016C (en) 2004-04-06
DE69033453T2 (de) 2000-09-21
JP2872172B2 (ja) 1999-03-17
AU6414390A (en) 1991-04-18
US20070003569A1 (en) 2007-01-04
US7279170B2 (en) 2007-10-09
JPH04501811A (ja) 1992-04-02
IL95742A (en) 2000-12-06

Similar Documents

Publication Publication Date Title
ES2144394T3 (es) Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis.
ATE251642T1 (de) Biologisch aktive fragmente des glucagon ähnlichen, insulinotropen peptides
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
PE117399A1 (es) CICATRIZACION DE FRACTURAS UTILIZANDO ANALOGOS DE PTHrP
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
MX9207334A (es) Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
SE7600284L (sv) Terapeutisk insulinberedning.
NZ517012A (en) Peptides that lower blood glucose levels
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
AR008555A1 (es) Constructo de acido nucleico para expresar sustancias activas que son activadas por una enzima que es liberada por celulas de mamifero, unprocedimiento para preparar un constructo de acido nucleico, el uso para preparar su farmaco, una celula alterada por medios recombinantes y una
ES2103928T3 (es) Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis.
ES2137182T3 (es) Derivados recombinantes del factor viii humano.
NO2000002I1 (no) Reteplase
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
ES2062982T3 (es) Clonaje y expresion del factor de crecimiento de fibroblasto acido.
DK274990D0 (da) Vaevsplasminogenaktivator-(t-pa)-varianter, dma-sekvenser, som koder for disse, replicerbare udtrykkelsesvektorer for dna-sekvenserne, eukaryote vaertsceller transformeret med vektorerne og farmaceutiske praeparater indeholdende t-pa-varianterne
ES2103596T3 (es) Utilizacion de un peptido que tiene un grupo lisina y un grupo alanina en posicion terminal para la preparacion de una composicion despigmentante y composicion despigmentante que comprende la aplicacion.
DK424387D0 (da) Humant placenta angiogen faktor, der er i stand til at stimulere syntesen af papillaer endothelial celleprotease, dna syntese og vandring
ES2064391T3 (es) Adn que codifica un polipeptido anticoagulante.
ES2071038T3 (es) Peptidos asociados al hiv.
NO881661D0 (no) Humane rhinoviruspeptider.
ES2055132T3 (es) Polipeptidos recombinantes del virus de la septicemia hemorragica de los peces.
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน
ECSP972184A (es) Vacuna polinucleotidica destinada a bovinos por via intradermica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 419355

Country of ref document: ES